ATE69266T1 - Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin. - Google Patents

Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin.

Info

Publication number
ATE69266T1
ATE69266T1 AT86302133T AT86302133T ATE69266T1 AT E69266 T1 ATE69266 T1 AT E69266T1 AT 86302133 T AT86302133 T AT 86302133T AT 86302133 T AT86302133 T AT 86302133T AT E69266 T1 ATE69266 T1 AT E69266T1
Authority
AT
Austria
Prior art keywords
production
methods
insulin
human insulin
precursors
Prior art date
Application number
AT86302133T
Other languages
English (en)
Inventor
Lars Thim
Kjeld Norris
Mogens Trier Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE69266T1 publication Critical patent/ATE69266T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Saccharide Compounds (AREA)
AT86302133T 1985-03-22 1986-03-21 Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin. ATE69266T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK129385A DK129385A (da) 1985-03-22 1985-03-22 Peptider og fremstilling deraf
EP86302133A EP0195691B1 (de) 1985-03-22 1986-03-21 Verfahren zum Herstellung von Insulin-Vorläufern und Verfahren zur Herstellung von Humaninsulin

Publications (1)

Publication Number Publication Date
ATE69266T1 true ATE69266T1 (de) 1991-11-15

Family

ID=8103207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86302133T ATE69266T1 (de) 1985-03-22 1986-03-21 Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin.

Country Status (16)

Country Link
EP (1) EP0195691B1 (de)
JP (3) JPH0648993B2 (de)
AT (1) ATE69266T1 (de)
AU (1) AU586855B2 (de)
CA (1) CA1340823C (de)
DE (1) DE3682303D1 (de)
DK (1) DK129385A (de)
ES (2) ES8802402A1 (de)
FI (1) FI87801C (de)
GR (1) GR860764B (de)
IE (1) IE58842B1 (de)
MX (1) MX163837B (de)
NO (1) NO172646C (de)
NZ (1) NZ215570A (de)
PT (1) PT82241B (de)
ZA (1) ZA861953B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
ATE69062T1 (de) * 1985-06-12 1991-11-15 Lubrizol Genetics Inc Modifiziertes zein.
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
DE3837271A1 (de) * 1988-11-03 1990-05-10 Hoechst Ag Verfahren zur selektiven spaltung von fusionsproteinen
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
ATE101620T1 (de) * 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
ES2081826T3 (es) * 1988-11-03 1996-03-16 Hoechst Ag Procedimiento para la preparacion de un producto previo de insulina en estreptomicetos.
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
PT93057B (pt) * 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
JP2857684B2 (ja) * 1989-05-04 1999-02-17 ジェネンテク，インコーポレイテッド ヒトリラキシンの単離のための方法および組成物
IL99383A (en) * 1990-09-05 1996-01-31 Hoechst Ag An enzymatic process for the conversion of pre-insulin into insulin
ZA928916B (en) * 1991-11-26 1994-05-18 Lilly Co Eli Tri-arginine insulins
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
NZ279002A (en) * 1994-12-29 1999-02-25 Bio Technology General Corp Production of recombinant human insulin by folding a proinsulin hybrid polypeptide obtained from a bacterial cell
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
WO1996034882A1 (en) * 1995-05-05 1996-11-07 Eli Lilly And Company Single chain insulin with high bioactivity
GB9513967D0 (en) * 1995-07-08 1995-09-06 Univ Leicester Insulin
KR100381494B1 (ko) * 1997-06-30 2003-07-22 바이오 테크놀로지 제네랄 코오포레이션 인간인슐린의제조방법
WO1999009816A1 (de) * 1997-08-22 1999-03-04 Roche Diagnostics Gmbh Verfahren zur gewinnung von insulin precursorproteinen
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AU4935701A (en) 2000-03-24 2001-10-08 Genentech Inc Use of insulin for the treatment of cartilagenous disorders
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
ES2545090T3 (es) 2001-12-21 2015-09-08 Human Genome Sciences, Inc. Proteínas de fusión de albúmina y GCSF
PL2307441T3 (pl) * 2008-08-07 2016-09-30 Sposób otrzymywania związków insuliny
AR072563A1 (es) * 2009-07-15 2010-09-08 Beta Lab Sa Un procedimiento para obtener insulina aspartica que utiliza una cepa de levaduras de pichia pastoris
PL239062B1 (pl) * 2016-01-22 2021-11-02 Inst Biotechnologii I Antybiotykow Sposób wytwarzania insuliny i jej pochodnych
JP2019530473A (ja) * 2016-09-06 2019-10-24 ケミカル アンド バイオファーマスーティカル ラボラトリーズ オブ パトラ エス．エー．Ｃｈｅｍｉｃａｌ ＆ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌ Ｌａｂｏｒａｔｏｒｉｅｓ Ｏｆ Ｐａｔｒａｓ Ｓ．Ａ． プロインスリン誘導体
KR102646845B1 (ko) * 2018-08-08 2024-03-14 주식회사 대웅제약 클로스트리파인을 이용한 지속형 인슐린 아날로그 복합체의 활성형 제조방법
KR102666154B1 (ko) * 2018-08-08 2024-05-20 주식회사 대웅제약 지속형 인슐린 아날로그 및 그 복합체
WO2020069040A1 (en) * 2018-09-25 2020-04-02 Amphastar Pharmaceuticals, Inc. Highly purified recombinant human insulin (rhi) api and methods of producing the same
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16156A (en) * 1980-03-27 1983-07-18 Lilly Co Eli Process for producing an insulin precursor
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
DK172738B1 (da) * 1983-04-07 1999-06-21 Chiron Corp Fremgangsmåde til at udtrykke modent insulin og DNA-struktur til anvendelse ved fremgangsmåden
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf

Also Published As

Publication number Publication date
DE3682303D1 (de) 1991-12-12
ES553231A0 (es) 1988-05-16
GR860764B (en) 1986-07-21
FI87801C (fi) 1993-02-25
JPH0648993B2 (ja) 1994-06-29
MX163837B (es) 1992-06-25
CA1340823C (en) 1999-11-16
NO172646C (no) 1993-08-18
JP2553326B2 (ja) 1996-11-13
NO861120L (no) 1986-09-23
AU586855B2 (en) 1989-07-27
IE860737L (en) 1986-09-22
AU5500586A (en) 1986-09-25
ES8708251A1 (es) 1987-10-01
JPH06133777A (ja) 1994-05-17
IE58842B1 (en) 1993-11-17
JPH0823985A (ja) 1996-01-30
JPS61221200A (ja) 1986-10-01
FI87801B (fi) 1992-11-13
EP0195691A1 (de) 1986-09-24
JPH088871B2 (ja) 1996-01-31
PT82241B (pt) 1988-11-30
PT82241A (en) 1986-04-01
ES557227A0 (es) 1987-10-01
NZ215570A (en) 1989-07-27
DK129385A (da) 1986-09-23
FI861198A (fi) 1986-09-23
NO172646B (no) 1993-05-10
ZA861953B (en) 1986-11-26
EP0195691B1 (de) 1991-11-06
DK129385D0 (da) 1985-03-22
FI861198A0 (fi) 1986-03-21
ES8802402A1 (es) 1988-05-16

Similar Documents

Publication Publication Date Title
ATE69266T1 (de) Verfahren zum herstellung von insulin-vorlaeufern und verfahren zur herstellung von humaninsulin.
ATE46358T1 (de) Verfahren zur zuechtung von lyophilisierten mikroorganismen.
ATE69241T1 (de) Herstellung von polypeptiden mit humangammainterferon-aktivitaet.
DE3778758D1 (de) Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.
ATE65797T1 (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens.
ATE295885T1 (de) Endo-xyloglucan-transferase
DE3751326D1 (de) Durch rekombinante DNS-Technologie konstruierte amylolytische enzymproduzierende Mikroorganismen und ihre Verwendung in Gärungsverfahren.
ATE66251T1 (de) Expressionsplasmide fuer die herstellung eines heterologen proteins in bakterien.
ATE90726T1 (de) Verfahren zur herstellung von menschlichem lysozym.
ATE89455T1 (de) Mittel zur bekaempfung von clostridien.
DE3783299D1 (de) Herstellung von mikroorganismen mit eiskristallbildungsaktivitaet.
ATE96843T1 (de) Verfahren zur herstellung von mikrobieller cellulose.
EP0302838A3 (en) Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme
DE58907274D1 (de) VERFAHREN ZUR STEIGERUNG VON ENZYM-AKTIVITÄTEN UND DER SYNTHESELEISTUNG VON MIKROORGANISMEN UND HöHEREN PFLANZEN.
ATE144554T1 (de) Mikrobiologisches verfahren zur herstellung von 6-hydroxypyrazincarbonsäure
ATE88758T1 (de) Verfahren zur herstellung von milchsaeure.
ATE250126T1 (de) Methode zur herstellung rekombinanter proteine und dafür verwendete wirtszellen
SU1566533A1 (ru) Способ изготовления вакцины против пастереллеза птиц

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee